Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPBWR1 | P48145 | 20/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31256796 | 0.92 | NPBWR1 (0.59) | NPBWR1 | |
| SCHEMBL31257043 | 0.91 | OPRM1 (0.56) | NPBWR1 | |
| SCHEMBL18862075 | 0.90 | NPBWR1 (0.60) | NPBWR1 | |
| SCHEMBL30219058 | 0.89 | ERAP2 (0.60) | NPBWR1 | |
| SCHEMBL18854324 | 0.88 | ERAP2 (0.58) | NPBWR1 | |
| SCHEMBL30199174 | 0.88 | NPBWR1 (0.57) | NPBWR1 | |
| SCHEMBL30169836 | 0.86 | ERAP2 (0.63) | NPBWR1 | |
| SCHEMBL29376430 | 0.86 | OPRM1 (0.61) | NPBWR1 | |
| SCHEMBL29589496 | 0.86 | GHSR (0.54) | — | |
| SCHEMBL5271284 | 0.86 | GHSR (0.55) | NPBWR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240190938-A1 | GIP DERIVATIVES AND USES THEREOF | NOVO NORDISK AS (DK) | 2024-06-13 | — | — | US | disclosed |
| US-11633459-B2 | GIP derivatives and uses thereof | NOVO NORDISK A/S (DK) | 2023-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11633459-B2 | GIP derivatives and uses thereof | GIPR, GLP1R, GPR119 | NPBWR1 21/4885 |
| US-20240190938-A1 | GIP DERIVATIVES AND USES THEREOF | GIPR, GLP1R, GPR119 | NPBWR1 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.